Blood test guides supplement choice to slow ALS in new trial
NCT ID NCT06429059
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 36 times
Summary
This pilot study tested whether personalized supplements could slow ALS progression. 50 participants had their blood analyzed to identify one of four disease categories (like inflammation or stress). Based on that, they received a specific supplement for 6 months. The goal was to see if this approach could slow the disease's effects on daily function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
-
Temple University
Philadelphia, Pennsylvania, 19122, United States
Conditions
Explore the condition pages connected to this study.